Please provide your email address to receive an email when new articles are posted on . Reoperation rate with surgical approaches was low but increased over time. Over 7 years, colpocleisis had the ...

Ten years ago, a discussion in Milan set a demanding project in motion. In a meeting between a biologist and a urologist, one ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...

Some people can manage a prolapsed bladder, or cystocele, with conservative treatments and without surgery. If a prolapse does not cause problems or block urine flow, it is unlikely to require surgery ...

Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC)—and after decades with few major advances, newly presented data may signal a turning point in how the disease is treated.

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for ...

Bladder prolapse can cause several symptoms, including a vaginal bulge, urinary incontinence, frequent voiding of the bladder, and more. There are three stages, or grades, of bladder prolapse. Females ...